Natus Medical (NASDAQ: NTUS)
Some price data may be temporarily unavailable.
Natus Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Natus Medical Company Info
A provider of healthcare products used for screening, detection, treatment, monitoring & tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, newborn jaundice & newborn metabolic testing.
News & Analysis
Why Natus Medical Stock Surged Today
A suitor wants to take the company private.
Is Natus Medical Stock a Buy?
What should investors think of this infant care and neurology specialist?
Here's Why NuVasive, Exelixis, and Natus Medical Fell Today
The healthcare companies couldn't sidestep the COVID-19 slump.
Natus Medical Is All Grown Up
This baby has a new ticker.
Natus Medical Continues Its Restructuring
It's a rebuilding year for the medical device maker.
1 Surprising Reason Alzheimer's Drugs Remain So Elusive
Most biotech drugs focus on clearing plaques from brain cells, but restoring patients' sleep quality is also proving to be necessary.
Why Natus Medical Stock Dropped 18.1% in February
It wasn't just lower-than-expected earnings that hurt the medical device company.
Natus Has Some Growing Up to Do
2019 will be a rebuilding year for the neurology and newborn-care specialist.
Valuation
Earnings Transcripts
Natus Medical Inc (NTUS) Q3 2021 Earnings Call Transcript
NTUS earnings call for the period ending September 30, 2021.
Natus Medical Inc (NTUS) Q2 2021 Earnings Call Transcript
NTUS earnings call for the period ending June 30, 2021.
Natus Medical Incorporated (NTUS) Q1 2021 Earnings Call Transcript
NTUS earnings call for the period ending March 31, 2021.
Natus Medical Incorporated (NTUS) Q4 2020 Earnings Call Transcript
NTUS earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.